Model 2 | B | SE | HR | 95% CI | p | |
---|---|---|---|---|---|---|
Inferior | Superior | |||||
Male gender | .68 | .23 | 1.97 | 1.27 | 3.08 | 0.003 |
Age | .09 | .01 | 1.09 | 1.06 | 1.12 | <0.001 |
Lipid- lowering drugs | -.57 | .24 | .56 | .35 | .91 | 0.019 |
Triglycerides ADA categories | ||||||
- Satisfying criteria | 1 | 0.025 | ||||
- Partially satisfying criteria | .72 | .30 | 2.05 | 1.14 | 3.68 | 0.017 |
- Not satisfying criteria | .55 | .24 | 1.73 | 1.08 | 2.77 | 0.022 |
Antidiabetic treatment | ||||||
- Diet | 1 | 0.006 | ||||
- Biguanides | -.79 | .38 | .45 | .22 | .96 | 0.038 |
- Sulfonylureas | -.73 | .64 | .48 | .14 | 1.68 | 0.253 |
- Biguanides + Sulfonylureas | -.86 | .35 | .42 | .21 | .84 | 0.014 |
- Insulin | .17 | .35 | 1.18 | .60 | 2.33 | 0.630 |
- Insulin + OHA | -.18 | .37 | .84 | .41 | 1.72 | 0.631 |